Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Omeros Corporation - Common Stock
(NQ:
OMER
)
19.78
+0.66 (+3.45%)
Delayed Quote
Updated: 2:47 PM EDT, Oct 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Omeros Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Omeros (OMER) Q2 2026 Earnings Call Transcript
↗
August 19, 2026
Yartemlia generated $32.2M in gross sales during its first full quarter on market.
Via
The Motley Fool
Topics
Derivatives
Earnings
Let's take a look at the stocks that are in motion in today's session.
↗
August 13, 2026
Via
Chartmill
There are notable gap-ups and gap-downs in today's session.
↗
August 13, 2026
Via
Chartmill
These stocks are moving in today's pre-market session
↗
August 13, 2026
Via
Chartmill
Omeros Corp (NASDAQ:OMER) Swings to Profit on YARTEMLEA Launch, Topping EPS Forecasts
↗
May 13, 2026
Via
Chartmill
Omeros Q2 Earnings Call Highlights
↗
August 12, 2026
Omeros (NASDAQ:OMER) reported second-quarter net sales of $28.5 million for YARTEMLEA, its newly launched treatment for hematopoietic stem cell transplant-associated thrombotic microangiopathy, or...
Via
MarketBeat
Topics
Earnings
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
August 12, 2026
Gainers ENvue Medical (NASDAQ:FEED) shares rose 49.1% to $0.61 during Wednesday's after-market session. The market value of their outstanding shares is at $2.4 million. Omeros (NASDAQ:OMER) stock moved...
Via
Benzinga
What's going on in today's after hours session
↗
August 12, 2026
Via
Chartmill
Omeros Corporation Reports Second Quarter 2026 Financial Results
August 12, 2026
From
Omeros Corporation
Via
Business Wire
Omeros Corporation to Announce Second Quarter Financial Results on August 12, 2026
August 10, 2026
From
Omeros Corporation
Via
Business Wire
CMS Grants New Technology Add-On Payment (NTAP) Status to YARTEMLEA®
August 03, 2026
From
Omeros Corporation
Via
Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER
July 28, 2026
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Omeros Corporation - OMER
July 21, 2026
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER
July 14, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Heartflow vs. Omeros: Which Healthcare Innovator Stock Is a Better Buy in 2026?
↗
July 08, 2026
Heartflow boasts rapid AI-driven growth but faces reimbursement headwinds, while Omeros bets everything on its first commercial launch.
Via
The Motley Fool
Topics
Artificial Intelligence
OMER Investors Have Opportunity to Join Omeros Corporation Fraud Investigation with the Schall Law Firm
July 08, 2026
From
Schall Law
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER
July 07, 2026
From
Pomerantz LLP
Via
GlobeNewswire
OMER Investors Have Opportunity to Join Omeros Corporation Fraud Investigation with the Schall Law Firm
July 06, 2026
From
The Schall Law Firm
Via
Business Wire
Which stocks are moving on Friday?
↗
June 26, 2026
Via
Chartmill
Traders are paying attention to the gapping stocks in Friday's session.
↗
June 26, 2026
Via
Chartmill
Top movers in Friday's pre-market session
↗
June 26, 2026
Via
Chartmill
Omeros Corporation Announces Update on European Marketing Authorization Application for Narsoplimab in TA-TMA
June 26, 2026
From
Omeros Corporation
Via
Business Wire
NovoCure vs. Omeros: Which Emerging Pharmaceutical Stock Is a Better Buy in 2026?
↗
June 22, 2026
Both companies target serious health challenges, but their financials and risk profiles reveal sharply different paths for growth-focused investors.
Via
The Motley Fool
Intellia Therapeutics vs. Omeros: Which Emerging Biotech Stock Is a Better Buy in 2026?
↗
June 20, 2026
Intellia's CRISPR pipeline and Omeros's newly approved therapy each bring unique risk and reward profiles, see how their financials and partnerships compare.
Via
The Motley Fool
Omeros Announces Webcast Details for Annual Meeting of Shareholders
June 15, 2026
From
Omeros Corporation
Via
Business Wire
Omeros (OMER) Q4 2025 Earnings Transcript
↗
June 01, 2026
Omeros (OMER) Q4 2025 Earnings Transcript
Via
The Motley Fool
Topics
Derivatives
Omeros (OMER) Q1 2026 Earnings Transcript
↗
May 14, 2026
Omeros (OMER) Q1 2026 Earnings Transcript
Via
The Motley Fool
Omeros Q1 Earnings Call Highlights
↗
May 14, 2026
Omeros (NASDAQ:OMER) reported first-quarter 2026 net income of $56.1 million, or $0.78 per share, as the company began commercial sales of YARTEMLEA, its recently approved treatment for hematopoietic...
Via
MarketBeat
Topics
Earnings
Omeros Corporation Reports First Quarter 2026 Financial Results
May 13, 2026
From
Omeros Corporation
Via
Business Wire
Omeros Corporation to Announce First Quarter Financial Results on May 13, 2026
May 11, 2026
From
Omeros Corporation
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
